Validea upgrades CPRX, AVAH, and CALM ratings based on solid fundamentals.

From NASDAQ.: 2025-07-02 05:30:00

Today’s upgrades for Validea’s Earnings Yield Investor model focus on CATALYST PHARMACEUTICALS INC (CPRX), a mid-cap value stock in the Biotechnology & Drugs industry. The rating has increased from 80% to 90% based on strong underlying fundamentals. CPRX markets three drug products for rare diseases. AVEANNA HEALTHCARE HOLDINGS INC (AVAH), a small-cap growth stock in the Healthcare Facilities industry, also saw a rating increase from 80% to 90%. AVAH provides diversified home care services. CAL-MAINE FOODS INC (CALM), a mid-cap value stock in the Fish/Livestock industry, received a top rating of 100% based on solid fundamentals. CALM is engaged in egg production and distribution. These upgrades are based on the strategy of Joel Greenblatt, who has a history of successful investing.



Read more at NASDAQ.: Validea Joel Greenblatt Strategy Daily Upgrade Report – 7/2/2025